Scleromyxedema revisited

International Journal of Dermatology

Volumn 42, Issue 1, 2003, Pages 31-35

  Pomann, John J ^a   Rudner, Earl J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; PLASMA PROTEIN; PSORALEN; RETINOID DERIVATIVE;

ACUTE HEART INFARCTION; CHEMOTHERAPY; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSPNEA; ELECTROMYOGRAPHY; ELECTRON BEAM; ELECTROPHORESIS; HEART BLOCK; HEART DISEASE; LOCALIZED SCLERODERMA; LUNG DISEASE; MULTIPLE MYELOMA; MUSCLE NECROSIS; MYOPATHY; NEPHROGENIC FIBROSING DERMOPATHY; PARAPROTEINEMIA; PERICARDIAL EFFUSION; PHOTOCHEMOTHERAPY; PLASMAPHERESIS; PUVA; REVIEW; SCLEROMYXEDEMA; SKIN BIOPSY; SYSTEMIC SCLEROSIS; TISSUE INJURY; AGED; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; MYXEDEMA; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RARE DISEASE; RISK ASSESSMENT; UNITED STATES;

AGED; BIOPSY, NEEDLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; MYXEDEMA; PROGNOSIS; RARE DISEASES; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 0038390404     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01565.x     Document Type: Review

References (39)

1. Rudner EJ, Mehregan A, Pinkus H. Scleromyxedema. A variant of Lichen myxedematosus. Arch Dermatol 1966; 93: 3-12.
2. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44: 273-281.
3. Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995; 33: 37-43.
4. Harris AO, Altman AR,Tschen JA, Wolf JE Jr. Scleromyxedema. Int J Dermatol 1989; 28: 661-667.
5. Pravata G, Noto G, Arico M. Scleromyxedema without paraproteinemia. G Ital Dermatol Venereol 1989; 124: 85-88.
6. Van Linthoudt D, Schumacher HR Jr, Algeo S, et al. Scleromyxedema with myopathy and hyperthyroidism. J Rheumatol 1996; 23: 1299-1301.
7. White GM, Jeffes EW 3rd. Stimulation of fibroblasts by para-protein in scleromyxedema. J Am Acad Dermatol 1989; 21: 816.
8. Ferrarini M, Helfrich DJ, Walker ER, et al. Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts. J Rheumatol 1989; 16: 837-841.
9. Yaron M, Yaron I, Yust I, Brenner S. Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts. J Rheumatol 1985; 12: 171-175.
10. Harper RA, Rispler J. Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science 1978; 199: 545-547.
11. Godby A, Bergstresser PR, Chaker B, Pandya AG. Fatal J scleromyxedema: report of a case and review of the literature. J Am Acad Dermatol 1998; 38: 289-194.
12. Lister RK, Jolles S, Whittaker S, et al. Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000; 43: 403-408.
13. Jennifer CC, Menter A. Diffuse eruption of pigmented papules. BUMC Proc 2001; 14: 185-186.
14. Yamazaki S, Fujisawa T, Yanatori A, Yamakage A. A case of lichen myxedematosus with clearly exacerbated skin eruptions after UVB irradiation. J Dermatol 1995; 22: 590-593.
15. Fleischmajer R. Papular mucinosis. In: Fitzpatrick TB, Freedberg IM, Eisen AZ, et al., eds. Dermatology in General Medicine. 5th edn. 1999: 2129-2131.
16. Matsuoka LY, Wortsman J, Carlisle KS, et al. The acquired cutaneous mucinoses. Arch Intern Med 1984 October; 144: 1974-1980.
17. Loggini B, Pingitore R, Avvenente A, et al. Lichen myxedematosus with systemic involvement: clinical and autopsy findings. J Am Acad Dermatol 2001; 45: 606-608.
18. Goldin HM, Axelrod AJ, Bronson DM, et al. Scleromyxedema with corneal deposits. Ophthalmology 1987; 94: 1334-1338.
19. Davis ML, Bartley GB, Gibson LE, Maguire LJ. Ophthalmic findings in scleromyxedema. Ophthalmology 1994; 101: 252-255.
20. Berger JR, Dobbs MR, Terhune MH, Maragos WF. The neurologic complications of scleromyxedema. Medicine 2001; 80: 313-319.
21. Alligood TR, Burnett JW, Raines BL Jr. Scleromyxedema associated with esophageal aperistalsis and dermal eosinophilia. Cutis 1981; 28 (60-3): 66.
22. River Y, Levy I, Gilead L, et al. Fever, convulsions and coma in scleromyxedema: a "dermato-neuro syndrome". Neurology 1996; 46: 1778-1779.
23. Gonzalez J, Palangio M, Schwartz J, et al. Scleromyxedema with dermato-neuro syndrome. J Am Acad Dermatol 2000; 42: 927-928.
24. Launay D, Hatron PY, Delaporte E, et al. Scleromyxedema (lichen myxedematosus) associated with dermatomyositis. Br J Dermatol 2001; 144: 359-362.
25. Helfrich DJ, Walker ER, Martinez AJ, Medsger TA Jr. Scleromyxedema myopathy: case report and review of the literature. Arthritis Rheum 1988; 31: 1437-1441.
26. Espinosa A, De Miguel E, Morales C, et al. Scleromyxedema associated with arthritis and myopathy: a case report. Clin Exp Rheumatol 1993; 11: 545-547.
27. Verity MA, Toop J, McAdam LP, Pearson CM. Scleromyxedema myopathy. Histochemical and electron microscopic observations. Am J Clin Pathol 1978; 69: 446-451.
28. Feasel AM, Donato ML, Duvic M. Complete Remission of Scleromyxedema Following Autologous Stem Cell Transplantation. Arch Dermatol 2001; 137: 1071-1072.
29. Farmer ER, Hambrick GW Jr, Shulman LE. Papular mucinosis. A clinicopathologic study of four patients. Arch Dermatol 1982; 118: 9-13.
30. McCarthy JT, Osserman E, Lombardo PC, Takatsuki K. An Abnormal Serum Globulin in Lichen Myxedematosus. Arch Dermatol 1964; 89: 446-450.
31. Herr HW. Major surgery and Scleromyxedema. N Engl J Med 1984; 310: 788-789.
32. Gabriel SE, Perry HO, Oleson GB, Bowles CA. Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Medicine (Baltimore) 1988; 67: 58-65.
33. Lang E, Goos M. Internal disease findings in Arndt-Gottron scleromyxedema. Dtsch Med Wochenschr 1986; 111: 820-813.
34. Cowper SE, Su LD, Bhawan J, et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001; 23: 383-393.
35. Alfadley A, Al Hoqail I, Al Eisa A. Scleromyxedema: possible association with seminoma. J Am Acad Dermatol 2000; 42: 875-878.
36. Lang E, Zabel M, Schmidt H. Arndt-Gottron Scleromyxedema and associated phenomena. Dermatologica 1984; 169: 29-35.
37. Wolbling RH, Milbradt R. Arndt-Gottron scleromyxedema without paraproteinemia. Dermatol Monatsschr 1986; 172: 217-222.
38. Kovary PM, Vakilzadeh F, Macher E, et al. Monoclonal gammopathy in scleredema. Observations in three cases. Arch Dermatol 1981; 117: 536-539.
39. Pusateri TJ, Margo CE, Groden LR. Corneal manifestations of Scleromyxedema. Ophthalmology 1987; 94: 510-513.